A Review of Daclatasvir Drug–Drug Interactions

Por Garimella, Tushar, You, Xiaoli, Wang, Reena, Huang, Shu-Pang, Kandoussi, Hamza, Bifano, Marc, Bertz, Richard, Eley, Timothy
Publicado no Adv Ther (2016)

Model‐based Meta‐Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis

Por Chan, Phyllis, Bax, Leon, Chen, Chunlin, Zhang, Nancy, Huang, Shu‐Pang, Soares, Holly, Rosen, Glenn, AbuTarif, Malaz
Publicado no CPT Pharmacometrics Syst Pharmacol (2017)

No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects

Por Ross, Lisa L., Song, Ivy H., Arya, Niki, Choukour, Mike, Zong, Jian, Huang, Shu-Pang, Eley, Timothy, Wynne, Brian, Buchanan, Ann M.
Publicado no BMC Infect Dis (2016)

Clinical and Pharmacogenetic Factors Affecting Neonatal Bilirubinemia Following Atazanavir Treatment of Mothers During Pregnancy

Por Eley, Timothy, Huang, Shu-Pang, Conradie, Francesca, Zorrilla, Carmen D., Josipovic, Deirdre, Botes, Mariëtte, Osiyemi, Olayemi, Hardy, Hélène, Bertz, Richard, McGrath, Donnie
Publicado em 2013

A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat

Por Tong, Gary, Wang, Jun-Sheng, Sverdlov, Oleksandr, Huang, Shu-Pang, Slemmon, Randy, Croop, Robert, Castaneda, Lorna, Gu, Huidong, Wong, Oi, Li, Hewei, Berman, Robert M, Smith, Christina, Albright, Charles F, Dockens, Randy
Publicado em 2013

Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

Por Pasquinelli, Claudio, McPhee, Fiona, Eley, Timothy, Villegas, Criselda, Sandy, Katrina, Sheridan, Pamela, Persson, Anna, Huang, Shu-Pang, Hernandez, Dennis, Sheaffer, Amy K., Scola, Paul, Marbury, Thomas, Lawitz, Eric, Goldwater, Ronald, Rodriguez-Torres, Maribel, DeMicco, Michael, Wright, David, Charlton, Michael, Kraft, Walter K., Lopez-Talavera, Juan-Carlos, Grasela, Dennis M.
Publicado em 2012